Daiwa Securities Group’s TherapeuticsMD TXMD Stock Holding History

Daiwa Securities Group’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-12	Closed	–	–	1428
2022 Q1	$0	Hold	12	–	–	﹤0.01%	1418
2021 Q4	$0	Hold	12	–	–	﹤0.01%	1445
2021 Q3	$0	Hold	12	–	–	﹤0.01%	1340
2021 Q2	$1K	Hold	12	–	–	﹤0.01%	1216
2021 Q1	$1K	Hold	12	–	–	﹤0.01%	1227
2020 Q4	$1K	Sell	12 -19	-61%	-$1.3K	﹤0.01%	1206
2020 Q3	$2K	Hold	31	–	–	﹤0.01%	1145
2020 Q2	$2K	Hold	31	–	–	﹤0.01%	1165
2020 Q1	$2K	Hold	31	–	–	﹤0.01%	1165
2019 Q4	$4K	Hold	31	–	–	﹤0.01%	1133
2019 Q3	$6K	Hold	31	–	–	﹤0.01%	1066
2019 Q2	$4K	Hold	31	–	–	﹤0.01%	1119
2019 Q1	$7K	Buy	31 +7	+29%	+$1.85K	﹤0.01%	1059
2018 Q4	$5K	Hold	24	–	–	﹤0.01%	1061
2018 Q3	$8K	Hold	24	–	–	﹤0.01%	1059
2018 Q2	$7K	Hold	24	–	–	﹤0.01%	1076
2018 Q1	$6K	Buy	+24	New	+$6.73K	﹤0.01%	1064

Other funds holding TXMD

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Daiwa Securities Group's TXMD Position: Q2 2022 in Review

Daiwa Securities Group sold out of TherapeuticsMD (TXMD) in Q2 2022, closing a stake of 12 shares.

Daiwa Securities Group first reported a position in TXMD in Q1 2018 and held it in 17 quarters. The position peaked at $8K in Q3 2018. 53 funds tracked by Wall St. Rank hold TXMD as of Q2 2022.

Daiwa Securities Group reported no remaining TherapeuticsMD position as of Q2 2022 after selling out during the quarter.
Daiwa Securities Group sold 12 TherapeuticsMD shares in Q2 2022.
Daiwa Securities Group first reported a position in TherapeuticsMD in Q1 2018 and held it in 17 quarters.
Daiwa Securities Group's TherapeuticsMD position peaked at $8K in Q3 2018.
53 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2022.

Based on Daiwa Securities Group's 13F filing for Q2 2022, filed 9 Aug 2022.